These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18922125)

  • 1. Resolving the controversies surrounding lymphatic mapping in breast cancer.
    Bergkvist L
    Future Oncol; 2008 Oct; 4(5):681-8. PubMed ID: 18922125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy indications and controversies in breast cancer.
    Wiatrek R; Kruper L
    Maturitas; 2011 May; 69(1):7-10. PubMed ID: 21411254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy for breast cancer: from investigational procedure to standard practice.
    Chagpar AB; McMasters KM
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):903-12. PubMed ID: 15485323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer.
    Ferrari A; Rovera F; Dionigi P; Limonta G; Marelli M; Besana Ciani I; Bianchi V; Vanoli C; Dionigi R
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1503-15. PubMed ID: 17069533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
    Newman EA; Cimmino VM; Sabel MS; Diehl KM; Frey KA; Chang AE; Newman LA
    Ann Surg Oncol; 2006 Jan; 13(1):52-7. PubMed ID: 16372155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A decade of sentinel lymph node biopsy for breast cancer: time for adaptations].
    Wobbes T
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):10-2. PubMed ID: 18240753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
    Port ER; Patil S; Stempel M; Morrow M; Cody HS
    Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The sentinel lymph node procedure also feasible in patients with recurrent breast cancer].
    Roumen RM; Kuijt GP; Liem LH
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):13-9. PubMed ID: 18240754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy, axillary dissection and breast cancer: radiation oncologist's viewpoint.
    Bansal M; Mohanti BK
    Natl Med J India; 2002; 15(3):154-7. PubMed ID: 12186329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of axillary sampling in the era of sentinel lymph node biopsy: a critical review.
    Bassi KK; Seenu V; Srivastava A; Al Sharara N
    Indian J Cancer; 2012; 49(1):66-73. PubMed ID: 22842171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.
    Roumen RM; Kuijt GP; Liem IH; van Beek MW
    Br J Surg; 2001 Dec; 88(12):1639-43. PubMed ID: 11736979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node mapping for breast cancer: progress to date and prospects for the future.
    Mabry H; Giuliano AE
    Surg Oncol Clin N Am; 2007 Jan; 16(1):55-70. PubMed ID: 17336236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.